Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Newsroom
In the News

July 29, 2014
Bioniche Announces Submission of Orphan Drug Designation Application for MCNA in the United States

July 18, 2014
Bioniche Announces Intention to File for Marketing Approval of MCNA in the United States

Investors

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Newsroom

Animal Health

February 2014

26/02/14
Vétoquinol to Acquire the Animal Health Business of Bioniche Life Sciences Inc.

December 2013

02/12/13
Bioniche Life Sciences Inc. Horse Product Approved for Sale in the U.S.

July 2013

15/07/13
Bioniche's Lead Animal Health Product Gains Access to Seven Additional European Markets

May 2013

13/05/13
Bioniche Engages Evercore Partners to Assist in the Divestment of its Animal Health Business

April 2013

18/04/13
Bioniche E. coli O157 Vaccine to be Used in an On-Farm Intervention Study in Sweden

March 2013

27/03/13
Bioniche Life Sciences Inc. Receives Government of Canada Support for Second Generation E. coli O157 Vaccine

January 2013

24/01/13
Bioniche Life Sciences Inc. Launches Two New Animal Health Products in Canada

December 2012

13/12/12
Bioniche Life Sciences Inc. Achieves Registration of Enhance™ I.A./I.V. in Hong Kong

04/12/12
Bioniche Life Sciences Inc. Launches NexHA™ in Canada

November 2012

21/11/12
U.S. Distributor Appointed for Bioniche’s ImmunocidinTM Canine Oncology Therapy

October 2012

17/10/12
Bioniche Life Sciences Inc. Announces North American Market Launch of ImmunocidinTM

September 2012

20/09/12
Bioniche Life Sciences Inc. Discovers a Counterfeit Equine Product

August 2012

20/08/12
Bioniche Launches New U.S. Equine Product and Acquires Canadian Distribution Rights to Six Additional Products

13/08/12
Bioniche Life Sciences Inc. Enters into an Exclusive U.S. Distribution Agreement for an Equine Product

07/08/12
Special Treatment Certificate Issued for Importation of E. coli O157 Vaccine into the United Kingdom

July 2012

31/07/12
Bioniche Presents Preliminary Data on the Use of In-Licensed Superagonist Hormone Technology in Cattle

23/07/12
Bioniche Life Sciences Inc. Moves Closer to Market Launch of ImmunocidinTM

May 2012

01/05/12
Bioniche Life Sciences Inc. Commercializing Two Products for Canine Cancer

April 2012

18/04/12
Bioniche Life Sciences Inc. Sponsors Two Major International Livestock Reproduction Conferences

March 2012

23/03/12
Bioniche Life Sciences Inc. Enters into a Distribution Agreement for New Animal Health Products in Australia

December 2011

21/12/11
Bioniche Life Sciences Inc. Enters into Two Distribution Agreements for New Animal Health Products

13/12/11
Bioniche E. coli Vaccine Granted Import Access to Australia

October 2011

27/10/11
Bioniche Life Sciences Inc. Receives Canadian Regulatory Approval for Equine Anti-Inflammatory Product

June 2011

13/06/11
Bioniche Chief Veterinary Scientific Officer Discusses Vaccine Against E. coli O157 at International Meat Industry Conference

May 2011

05/05/11
Econiche™ Vaccine Efficacy Challenge Study Summarized in The Canadian Journal of Veterinary Research

April 2011

29/04/11
Animal Health and Food Safety Vaccine Manufacturing Centre Officially Opens in Belleville, Ontario, Canada

March 2011

22/03/11
Bioniche Life Sciences Inc. Keynote Speaker at 7th Annual NZBIO Conference in New Zealand

November 2010

30/11/10
Bioniche Obtains Exclusive U.S. Rights to Equine Reproductive Product from CreoSalus

15/11/10
Bioniche Presents at U.S. Animal Health Association Committee on Food & Feed Safety

October 2010

18/10/10
Bioniche Scientists Present at Modern Vaccine & Adjuvant Formulation Conference in France

June 2010

23/06/10
Bioniche & Trophogen Sign Exclusive Global Veterinary License Agreement for Superagonist Hormone Technology Platform

02/06/10
Bioniche Animal Health Partners with Bayer Australia to Distribute Livestock Product Line

September 2007

06/09/07
Bioniche Responds to Australian Equine Influenza Outbreak

April 2007

03/04/07
Non-Antibiotic Treatment for Equine Endometritis Study Data Published in International Peer-Reviewed Journal

June 2006

05/06/06
Counterfeit Product Linked to Death of Ontario Horse

03/06/05
New Studies Demonstrate Immunomodulatory Activity of Bioniche Technology in Dogs

May 2005

24/05/05
Bioniche Mycobacterial Cell Wall Extract (MCWE) Granted New Patent for Production Performance in Animals

March 2005

07/03/05
Research Shows Promise for Easy, Effective Management of Sow Breeding

January 2005

21/01/05
Bioniche Receives Authorization to Market Folltropin®-V in Additional EU Countries

December 2004

03/12/04
Livestock Revolution in Global Agriculture

November 2004

29/11/04
New Treatment for Equine Endometritis Given USDA Approval

August 2004

06/08/04
Mycobacterial Cell Wall Formulation Shows Promise in Treating Equine Endometritis

03/08/04
Bomac Laboratories Ltd. to Distribute Bioniche Cue-Mate® Technology in New Zealand

June 2004

21/06/04
Bioniche Commences Sales of Cue-Mate® Animal Reproductive Technology in Australian Cattle Market

18/06/04
Bioniche Receives Approval For New Animal Health Product Indication

10/06/04
Bioniche Presents Positive Data on Anti-Cancer Activity of MCC at 22nd Annual Meeting of American College of Veterinary Internal Medicine

April 2004

19/04/04
Bioniche Acquires Cue-Mate® Reproductive Technology From Pfizer

January 2004

10/01/04
Bioniche Life Sciences and AB Technology Sign Purchase Agreement


Newsroom

Categories:
All Releases
Archived Releases
Animal Health
Corporate
Financial
Human Health
One Health

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy